iX Biopharma Ltd. said it allotted and issued 1,362,355 new ordinary shares on Jul, 20 2026 following the exercise of warrants at an exercise price of 0.06 Singapore dollars per share.

The issuance lifts the company’s total outstanding shares to 1,093,315,474 from 1,091,953,119. The new shares will rank pari passu with existing shares and are expected to start trading on the Singapore Exchange on or around Jul, 22 2026.

All remaining unexercised warrants expired at 5:00 p.m. on Jul, 17 2026, in accordance with the warrant conditions, and are now void.